Anthony T. Blikslager, DVM, PhD, DACVS

Anthony T. Blikslager, DVM, PhD, DACVS

Anthony T. Blikslager, DVM, PhD, DACVS, is assistant professor of equine surgery at North Carolina State University, where he also has a federally-funded research program in the role of COX inhibitors in equine colic, and has recently become interested in the use of COX-2 inhibitors for treatment of lameness.

Articles by Anthony T. Blikslager, DVM, PhD, DACVS

Small colon impaction is a relatively infrequent cause of colic. However, when it does occur, it can be difficult to recognize and to manage. We have noticed over the last several years that many of these cases are initiated by diarrheal disease, making the eventual diagnosis of an obstructive condition unexpected by the veterinarian.

Strangulation obstruction of the small intestine is frequently fatal because of simultaneous occlusion of the intestinal lumen and its blood supply, resulting in progressive necrosis of the mucosa, and development of endotoxemia. Among the more common causes of this condition are strangulating lipomas and entrapment within a natural internal opening or a mesenteric defect.

In horses with primary cecal impactions, there is a gradual onset of abdominal pain similar to the development of a large colon impaction. The typical time course is 5-7-days. During this time, veterinarians may use treatments for impactions, such as intravenous administration of analgesics and nasogastric administration of laxatives such as mineral oil, dioctyl sodium sulfocuccinae (DSS) or magnesium sulphate (Epsom salts).

Although there has been a substantial increase in our understanding of postoperative complications in recent years, the treatments remain very much the same. For ileus, these treatments include decompression of the stomach, replacement of fluid and electrolyte losses with parenteral fluids, and use of a variety of prokinetic agents. For adhesions, treatments include anti-inflammatory medications and antibiotics, although some of the newer physical agents such as carboxymethylcellulose offer new modalities for combating this problem.

image1-31534-1384864083146.jpg

Treatment of painful conditions in horses has relied largely on nonsteroidal anti-inflammatory drugs (NSAIDs) for much of the last 25 years. For example, flunixin meglumine (Banamine®) and phenylbutazone (Butazolidin®) have dominated the market for treatment of colic and lameness respectively. However, it is becoming increasingly clear that these drugs also have some side effects, most notably gastrointestinal ulceration.

Latest Updated Articles